SS Innovations said its SSI Mantra surgical robotic system has now been used in more than 10,500 surgeries as of April 30, 2026, up from the prior milestone of 10,000 surgeries reached less than a month earlier. The company also said the system has now been used for more than 500 cardiac procedures, 170 telesurgeries and 125 pediatric surgeries.
The company said about 2,100 physicians have been trained on the system, and the platform has been used to perform more than 170 different procedure types.
SS Innovations said its global installed base has grown to more than 200 systems across 11 countries, compared with its commercial launch in August 2022, when the system had no installed base in market. As a result of these announcements, the company's shares have moved 0.99% on the market, and are now trading at a price of $4.09. Check out the company's full 8-K submission here.
